Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...

IceCure Medical (ICCM) announced it is in continued discussions with the U.S. FDA regarding its De Novo marketing authorization request for ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

A new research paper was published by Aging (Aging-US) on March 7, 2025, titled "Accelerated aging associated with cancer characteristics and treatments among breast cancer survivors." ...

Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025MBX 1416 Phase 2 trial in ...